Shire Cuts 2013 Sales Forecast as Revenue Misses Estimates

Shire Plc, the world’s largest seller of attention-deficit drugs, cut its full-year sales forecast after first-quarter revenue missed analysts’ estimates, partly because of increased competition from Sanofi.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.